Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Graminn Forte is a multi-ingredient dietary supplement developed by INNventa Pharm for the management of prostate health. It contains a synergistic blend of saw palmetto fruit extract, nettle root extract, rye seed extract, purified pollen extracts, zinc, and selenium. The formulation is designed to alleviate urinary symptoms associated with benign prostatic hyperplasia (BPH), such as frequent and urgent urination, and to reduce inflammation and swelling of prostate tissue. Additionally, it is used for acute and chronic prostatitis, chronic pelvic pain, and to support erectile function. As a phytotherapeutic product, it represents a natural approach to urological health management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Graminn Forte.